Caspase-3–Mediated NDUFS1 Cleavage Drives Hepatic ROS in Trichothecene Toxicity

Study Background and Research Question

Trichothecene mycotoxins, especially deoxynivalenol (DON) and T-2 toxin, are globally prevalent contaminants of grains and animal feed, posing significant risks to food safety and public health. Their toxicity is strongly linked to the induction of oxidative stress, particularly through the accumulation of reactive oxygen species (ROS) that disrupt cellular homeostasis and contribute to liver damage. While prior research established that trichothecenes impair mitochondrial function and activate apoptotic pathways, the precise mechanisms by which these toxins dysregulate redox balance and promote ROS generation remained unresolved. Addressing this gap, the reference study (SSRN preprint) sought to define the molecular events linking trichothecene exposure to ROS accumulation and hepatocellular injury, focusing on the roles of mitochondrial complex I and ER oxidative pathways.

Key Innovation from the Reference Study

The central innovation of this work lies in identifying caspase-3–mediated cleavage of NDUFS1, a core subunit of mitochondrial complex I, as a pivotal event in trichothecene-induced ROS production. The study demonstrates that activation of caspase-3 following toxin exposure directly targets NDUFS1, disrupting electron transport chain (ETC) function and amplifying mitochondrial ROS. Furthermore, the research uncovers a feedback loop in which endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) serves as a secondary, non-mitochondrial source of ROS, compounding oxidative damage. By characterizing the interplay between mitochondria and ER in redox dysregulation, the study provides novel mechanistic insight and points to new intervention strategies for mycotoxin-induced hepatotoxicity.

Methods and Experimental Design Insights

The authors employed a combination of in vivo and in vitro approaches. Mice were exposed to DON and T-2 toxin, and hepatocyte cell cultures were treated with these toxins to model acute and controlled conditions. Key methodological highlights include:

• Pharmacological and genetic inhibition of caspase-3 to assess its role in ROS generation and mitochondrial dysfunction.
• Mutagenesis of the caspase-3 cleavage site in NDUFS1 (D255A) to evaluate the necessity of this event for ROS amplification.
• Assessment of mitochondrial membrane potential, ROS levels, and ETC activity, with a focus on functional consequences of NDUFS1 cleavage.
• Investigation of ERO1α as a non-mitochondrial ROS source through inhibitor studies and knockdown experiments.

Fluorescent probes for mitochondrial membrane potential and ROS detection were essential for quantifying mitochondrial health and oxidative status under varying experimental conditions.

Core Findings and Why They Matter

1. Caspase-3 Activation Is Central to Trichothecene-Induced ROS Accumulation: Both genetic and pharmacological inhibition of caspase-3 significantly reduced ROS levels and protected against mitochondrial damage in toxin-exposed cells and animals. This establishes caspase-3 as a molecular switch for downstream oxidative events.

2. NDUFS1 Cleavage Disrupts ETC and Drives Mitochondrial ROS: The study confirms that activated caspase-3 cleaves NDUFS1, leading to ETC impairment and overproduction of mitochondrial ROS. Expression of a cleavage-resistant NDUFS1 mutant (D255A) conferred protection, supporting the specificity and necessity of this event for pathogenesis (reference study).

3. ERO1α Provides an Additional Source of ROS: The authors reveal that ER-localized ERO1α contributes to ROS generation, forming a positive feedback loop with mitochondrial dysfunction. This cross-organelle interaction underscores the complexity of redox signaling and highlights ERO1α as a potential therapeutic target.

4. Implications for Hepatotoxicity: By mapping the cascade from trichothecene exposure to caspase-3 activation, NDUFS1 cleavage, mitochondrial depolarization, and ER oxidative stress, the research clarifies how these toxins precipitate liver injury. This mechanistic understanding is critical for developing targeted interventions to protect against mycotoxin-related diseases.

Comparison with Existing Internal Articles

The mechanistic insights from this study closely align with and expand upon recent work in the field of mitochondrial dysfunction assays. For example, the article "Caspase-3, NDUFS1 Cleavage, and ER ROS in Trichothecene Toxicity" echoes the reference study's findings on the centrality of caspase-3 and NDUFS1 in linking mitochondrial and ER-derived ROS, reinforcing the significance of these targets in hepatotoxicity research.

Moreover, "Redefining Mitochondrial Dysfunction Assays: TMRE’s Strategic Value" highlights the utility of rhodamine-like fluorescent dyes, such as Tetramethylrhodamine ethyl ester perchlorate, for precise quantification of mitochondrial membrane potential and early detection of mitochondrial dysfunction. The reference study’s use of mitochondrial membrane potential assays is consistent with these recommendations, demonstrating how such probes can reveal subtle changes in mitochondrial health that precede overt cell death.

Further, the "Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria Imaging" article provides additional protocol-level guidance for live-cell mitochondrial staining and underscores the dye's sensitivity in tracking oxidative stress and apoptosis—capabilities directly relevant to the reference study’s workflow.

Limitations and Transferability

While the study provides compelling evidence for the caspase-3/NDUFS1/ERO1α axis in trichothecene-induced ROS accumulation, several limitations should be noted. The research primarily utilizes acute toxin exposure models in mice and cultured hepatocytes; thus, the chronic effects of lower-dose, long-term exposure require further exploration. The findings are currently limited to hepatic tissue, and their applicability to other organs or species, including humans, must be validated. Additionally, while the feedback loop between mitochondria and ER is well-supported, the broader network of ROS-regulatory pathways may involve additional factors not addressed here. Nevertheless, the identified mechanisms offer a strong foundation for translational studies and therapeutic exploration.

Protocol Parameters

• Trichothecene exposure: Acute in vivo administration of DON or T-2 toxin; dosing and duration as modeled in the reference study.
• Caspase-3 inhibition: Use of genetic knockdown or specific pharmacological inhibitors to assess effects on ROS and mitochondrial function.
• Mutagenesis: Site-directed mutagenesis of NDUFS1 (D255A) to generate cleavage-resistant variants for functional assays.
• Mitochondrial membrane potential assay: Employ a rhodamine-like fluorescent dye for live-cell quantification of ΔΨm and detection of mitochondrial dysfunction.
• ERO1α modulation: Utilize siRNA knockdown or small-molecule inhibitors to evaluate non-mitochondrial ROS contributions.

Research Support Resources

For researchers aiming to replicate or extend these findings, robust detection of mitochondrial membrane potential and ROS is critical. Tetramethylrhodamine ethyl ester perchlorate (SKU: C8197) is a validated, rhodamine-like fluorescent dye optimized for live-cell mitochondrial staining and fluorescence-based assessment of mitochondrial health. Its use supports sensitive, quantitative measurements of mitochondrial membrane potential in workflows investigating oxidative stress and mitochondrial dysfunction, as described in both the reference study and related literature. APExBIO supplies this probe for research use, enabling precise mitochondria fluorescence imaging across diverse cell models.